Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Insulin-like Growth Factor-1 in post-pneumonectomy lung regeneration

Yasa, Joe (2019) Insulin-like Growth Factor-1 in post-pneumonectomy lung regeneration. PhD thesis, Murdoch University.

PDF - Whole Thesis
Download (6MB) | Preview


Insulin Growth Factor-1 (IGF-1), is a key and highly regulated molecule which stimulates somatic growth. The level of serum IGF-1 in humans peaks at adolescence and declines with age. IGF-1 expression is also critical for embryonic lung development and is expressed in the regenerating lung of young animals following pneumonectomy (PNX), the surgical removal of a lung. The murine left-lung PNX model was used to investigate the hypothesis that IGF-1 enhances the regenerative capacity of the lung. The potential interactions of IGF-1 and the transcription factors early growth response protein 1 (EGR-1) and hypoxia-inducible factor-1α (HIF-1α) in post-PNX lung growth was also investigated.

I demonstrated that following left-lung PNX in young mice (aged 2-3 months) pre-operative total lung volume and tissue volume is restored by day 21 post-surgery. IGF-1 mRNA and protein levels were significantly induced in the remaining lung, with a transient but significant increase in IGF-1+, pIGF-1R+ and pERK-1/2+ lung cells, at day three post-PNX compared to SHAM treated mice. I then showed that intraperitoneal administration of IGF-1 following PNX significantly increases the rate of lung volume and tissue volume recovery and the level of lung cell proliferation, when assessed at day seven post-surgery. In contrast, blocking IGF-1 activity by pharmacological inhibition of IGF-1R signalling, significantly attenuated post-PNX lung growth.

In young mice receiving continuous subcutaneous infusion of IGF-1 following PNX, the rate of lung volume recovery to pre-operative levels was similar to age-matched PBS-treated PNX mice. However, lung sections assessed at day 23 post-surgery revealed that IGF-1-treated mice lungs had significantly higher numbers of IGF-1+, pIGF-1R+, pERK-1/2+ lung cells, proliferating SpC+ type two alveolar epithelial cells and number of alveoli per unit area, suggesting that IGF-1 treatment was associated with additional regenerative activity.

In old PNX mice (aged 22-24 months), there was a significant increase in aerated lung volume following continuous subcutaneous administration of IGF-1, compared to age-matched PBS-treated controls. However, unlike young mice, there was no evidence of restoration of pre-operative total lung volume or tissue volume by day 21 post-surgery in either treatment groups. Additionally, lung sections assessed at day 23 post-surgery revealed no differences between IGF-1 and PBS treated lungs in the numbers of IGF-1+, pIGF-1R+ and pERK-1/2+ lung cells, or proliferating SpC+ alveolar type two epithelial cells or the number of alveoli per unit area.

Finally, I investigated the potential for interactions of IGF-1 and the transcription factors EGR-1 and HIF-1α in post-PNX lung growth. I demonstrated that IGF-1 treatment can induce EGR-1 and HIF-1α protein expression in cultured 3T3 fibroblasts. Furthermore, both EGR-1 and HIF-1α were transiently increased in the parenchyma of the lung at day three post-PNX, coinciding with the peak of IGF-1 expression. Pharmacological inhibition of either EGR-1 or HIF-1α activity significantly reduced the density of CD31+ cells and CD31 protein levels in the lung. Additionally, pharmacological inhibition of HIF-1α activity in the lung following PNX significantly reduced lung cell proliferation at day seven post-surgery. Intraperitoneal administration of IGF-1 was able to restore the level of lung cell proliferation in HIF-1α inhibited PNX lungs to the levels of untreated PNX lungs.

These results collectively point to a temporally coordinated involvement IGF-1, EGR-1 and HIF-1α during post-PNX regenerative lung growth, and that additional IGF-1 treatment can enhance such growth following PNX in young mice, but not in aged mice. Furthermore, these studies have identified a potential age-dependent defect in responsiveness to IGF-1 in the lung, which warrants further investigation.

Item Type: Thesis (PhD)
Murdoch Affiliation(s): School of Veterinary and Life Sciences
United Nations SDGs: Goal 3: Good Health and Well-Being
Supervisor(s): Mead, Robert
Item Control Page Item Control Page


Downloads per month over past year